WITHDRAWN: Th17 Overexpression in Severe COVID-19: A Prospective Observational Study

Q3 Pharmacology, Toxicology and Pharmaceutics

Infectious disorders drug targets Pub Date : 2023-05-31 DOI:10.2174/1871526523666230531115839

Ankesh Gupta, Arvind Kumar, Rakesh Kumar Deepak, Umang Arora, Aayush Agrawal, Manish Soneja, Prerna Garg, Sanchit Kumar, Praveen Kumar, Uma Kanga, Ganesh Kumar V, Kapil Dev Soni, Naveet Wig

{"title":"WITHDRAWN: Th17 Overexpression in Severe COVID-19: A Prospective Observational Study","authors":"Ankesh Gupta, Arvind Kumar, Rakesh Kumar Deepak, Umang Arora, Aayush Agrawal, Manish Soneja, Prerna Garg, Sanchit Kumar, Praveen Kumar, Uma Kanga, Ganesh Kumar V, Kapil Dev Soni, Naveet Wig","doi":"10.2174/1871526523666230531115839","DOIUrl":null,"url":null,"abstract":"Since the authors are not responding to the editor’s requests to fulfil the editorial requirement, therefore, the article has been withdrawn from the journal \"Infectious Disorders - Drug Targets\"Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.Bentham science disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.","PeriodicalId":13678,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871526523666230531115839","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 0

Abstract

Since the authors are not responding to the editor’s requests to fulfil the editorial requirement, therefore, the article has been withdrawn from the journal "Infectious Disorders - Drug Targets"

Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.

Bentham science disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

查看原文本刊更多论文

撤回：严重 COVID-19 中 Th17 过度表达：一项前瞻性观察研究

由于作者没有回应编辑的要求以满足编辑的要求，因此，该文章已从《感染性疾病--药物靶点》杂志中撤下。Bentham Science免责声明：向本刊投稿的稿件未曾在其他地方发表过，也不会同时在其他地方投稿或发表，这是发表的条件之一。此外，任何已在其他地方发表的数据、插图、结构或表格都必须报告，并且必须获得复制的版权许可。严禁剽窃，一旦发现剽窃或捏造信息，作者同意出版商有法律权利对作者采取适当行动。提交稿件即表示作者同意，如果文章被接受发表，其版权即转让给出版商。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Infectious disorders drug targets Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

3.10

自引率

0.00%

发文量

123

期刊介绍： Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continues to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.